Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...
Going into the new year 2025, the German economy remains stuck in recession, with a crisis in the country's all-important automotive industry significantly contributing to the downturn. The current ...